Marc Oliva, Santiago Cabezas-Camarero, Alejandro Olivares-Hernández, Manuel Chaves, Ana Medina-Colmenero, Sandra Llop-Serna, Virginia Arrazubi, Maria José Flor, Nerea Munoz-Unceta, Isaac Ceballos, Lara Iglesias Docampo, Gloria Serrano, Marisa Durán, Carmen Montalbán, Pedro Pérez-Segura, Ricard Mesia, Neus Baste. "ERBIOTAX (TTCC-2022-02): A phase II, multicenter, randomized study of cetuximab with or without weekly paclitaxel after progression on first-line pembrolizumab plus platinum/5-FU in recurrent or metastatic head and neck squamous cell carcinoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps6131